the Influence of Sleep Improvement Through Different Methods on Patients in ICU

Chinese Medical Association

Status: Unknown

Conditions: Metabolic Problems; Sleep

Treatments: Device: eye patch; Drug: Dexmedetomidine

Study type: Interventional

Funder types: NETWORK

Identifiers

NCT03480789

sleep in ICU

Details and patient eligibility

About

In the research, we enroll 120 postoperative patients in the ICU and they will be assigned to four group: the eye patch group, the Dexmedetomidine(DEX) group, the eye patch+DEX group and the usual group. The sleep quality would be evaluated by the EEG monitor and the metabolic level, the inflammation and nutrition status would be detected.

Full description

In the research, we enroll 120 postoperative patients in the ICU and they will be assigned to four group: the eye patch group, the Dexmedetomidine(DEX) group, the eye patch+DEX group and the usual group. The sleep quality would be evaluated by the EEG monitor and the metabolic level, the inflammation and nutrition status would be detected. The research aims to confirm that the sleep quality could have a great influence on patients in the ICU and different interventions would make various changes.

Enrollment: 120 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• the postoperative patients that admission to icu is more than 48h

Exclusion criteria

• pregnant or breastfeeding
• sleep disorders before operation
• poor liver or kidney function
• post craniocerebral operation

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

120 participants in 4 patient groups

eye patch

Experimental group

Description:

wearing the eye patch from 22:00 to 6:00 of the next day

Treatment:

Device: eye patch

Dexmedetomidine

Experimental group

Description:

given dexmedetomidine to meet RASS -1 from 22:00 to 6:00 of the next day

Treatment:

Drug: Dexmedetomidine

eye patch + DEX

Experimental group

Description:

given dexmedetomidine to meet RASS -1 and wearing the eye patch from 22:00 to 6:00 of the next day

Treatment:

Drug: Dexmedetomidine

Device: eye patch

usual treatment

No Intervention group

Description:

treatment as usual